JAK2 V617F Mutation, Quantitative

The JAK2 V617F Mutation, Quantitative test contains 1 test with 2 biomarkers.

JAK2 V617F Mutation, Quantitative

Clinical Significance

Detection of JAK2 mutation is important for diagnosis and monitoring of chronic myeloproliferative neoplasms. This cell-based pyrosequencing assay determines the percentage of mutated allele compared to unmutated allele, down to 1% sensitivity and is available for use on blood, bone marrow or formalin-fixed paraffin-embedded tissue blocks, including bone marrow biopsies.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Jak2 V617f Mutation Quantitative

Jak2 V617f Mutation Level

Methodology:

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.